Patents by Inventor Olga Sarre

Olga Sarre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4962146
    Abstract: 3-O-Glycosyl derivatives of 16-membered macrolides such as O-.alpha.-L-cladinosyl-(1.fwdarw.3)-12,13-dehydro-12,13-deoxorosaramicin, 2", 4",4'"-tri-O-acetyl-O-(4'-O-phenoxyacetyl-.alpha.-L-cladinosyl)-(1.fwdarw. 3)-desmyconsin and pharmaceutically acceptable acid addition salts thereof useful as antibacterials are disclosed.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: October 9, 1990
    Assignee: Schering Corporation
    Inventors: Alan K. Mallams, Randall R. Rossman, Olga Sarre, Viyyoor M. Girijavallabhan, Ashit K. Ganguly
  • Patent number: 4767748
    Abstract: A compound represented by formula I ##STR1## wherein R is hydrogen, or ##STR2## wherein R.sup.1 is N-acylamino, N-alkylamino, N,N-dialkylamino, N-acyl-N-hydroxylamino, nitroso or the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: July 30, 1988
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Olga Sarre, Viyyoor M. Girijavallabhan
  • Patent number: 4622314
    Abstract: There is disclosed desevernitrose, acetamido, ethylamino and diethylamino derivatives of antibiotic 13-384 components 1 and 5 represented by the following formula ##STR1## wherein R is hydrogen, or ##STR2## wherein R.sup.1 is acetamide, ethylamine, diethylamine, N-hydroxylamino, nitroso or the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 15, 1985
    Date of Patent: November 11, 1986
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Olga Sarre, Viyyoor M. Girijavallabhan
  • Patent number: 4373095
    Abstract: Desmycinosyl derivatives of 12,13-desepoxy-12,13-dehydro antibiotic AR-5 component 1 and 12,13-desepoxy-12,13-dehydro antibiotic AR-5 component 2 are useful antibacterial agents and may be converted to other such agents by processes analogous to those generally known in the art.
    Type: Grant
    Filed: March 17, 1981
    Date of Patent: February 8, 1983
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Olga Sarre, Yi-Tsung Liu
  • Patent number: 4366309
    Abstract: Novel macrolide antibacterial derivatives of the components of the Antibiotic AR-5-complex are disclosed herein. The invention specifically relates to compounds wherein the macrolide ring and/or the two attached sugars are derivatized. Also disclosed are methods for the preparation of the derivatives and methods for the use thereof.
    Type: Grant
    Filed: April 13, 1981
    Date of Patent: December 28, 1982
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Yi-Tsung Liu, Olga Sarre, Robert Jaret, Doris P. Schumacher
  • Patent number: 4283531
    Abstract: .beta.-Lactams having a substituted hydroxymethylene group at the position .alpha. to the lactam carbonyl group are prepared by reaction of an .alpha.-halo-.beta.-lactam with zinc or zinc amalgam in an anhydrous aprotic medium to produce an intermediate which in situ reacts with an appropriate aldehyde or ketone.Also described are novel penicillins and cephalosporins having useful antibacterial activity.
    Type: Grant
    Filed: October 4, 1979
    Date of Patent: August 11, 1981
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Viyyoor M. Girijavallabhan, Patricia Cavender, Olga Sarre, Stuart W. McCombie
  • Patent number: 4272439
    Abstract: .beta.-Lactams having a substituted hydroxymethylene group at the position .alpha. to the lactam carbonyl group are prepared by reaction of an .alpha.-halo-.beta.-lactam with zinc or zinc amalgam in an anhydrous aprotic medium to produce an intermediate which in situ reacts with an appropriate aldehyde or ketone.Also described are noval penicillins and cephalosporins having useful antibacterial activity.
    Type: Grant
    Filed: June 2, 1978
    Date of Patent: June 9, 1981
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Viyyoor M. Girijavallabhan, Patricia Cavender, Olga Sarre, Stuart W. McCombie
  • Patent number: 4129720
    Abstract: Everninomicin B, C or D may be converted to amino derivatives by reductive means. The amino derivatives may, subsequently, be converted to novel N-acyl, N-alkyl or N,N-dialkyl derivatives. Alternatively, everninomicins B, C or D may be converted to N-acyl-N-hydroxylamino derivatives also by reductive means. The derivatives so-produced and the non-toxic pharmaceutically acceptable cationic salts thereof are novel and are antibacterial agents.
    Type: Grant
    Filed: September 16, 1977
    Date of Patent: December 12, 1978
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Viyyoor M. Girijavallabhan, Olga Sarre, Hans Reimann
  • Patent number: 4006225
    Abstract: Everninomicin antibiotics having a nitro function, e.g. everninomicin B, everninomicin C, and everninomicin D, upon treatment with aluminum amalgam in aqueous alkanol are converted to a mixture of at least two reduction products having antibacterial activity, said reduction products being an everninomicin having a nitroso function and an everninomicin having a hydroxylamino function. The nitrosoeverninomicins are also prepared by treating the corresponding hydroxylaminoeverninomicin with an oxidizing reagent selected from the group consisting of aerial oxidation in alkaline solution, and an alkali metal hypobromite in an aprotic solvent. The everninomicin reduction products and salts thereof are described as well as nitrone derivatives of the hydroxylaminoeverninomicins and salts thereof, all of which possess antibacterial activity. A preferred compound is hydroxylaminoeverninomicin D, particularly the sodium salt thereof.
    Type: Grant
    Filed: April 21, 1975
    Date of Patent: February 1, 1977
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Olga Sarre
  • Patent number: 3975372
    Abstract: Described is a novel process for the preparation of 12,13-desepoxy-12,13-dehydrorosamicin by reducing rosamicin in a mineral acid solution containing Cr.sup.+.sup.+ cations. Rosamicin is an antibiotic elaborated by Micromonospora rosaria.
    Type: Grant
    Filed: February 28, 1975
    Date of Patent: August 17, 1976
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Olga Sarre